QC
PYXS icon

Quadrature Capital’s Pyxis Oncology PYXS Stock Holding History

Quadrature Capital’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
+47,067
New +$90K ﹤0.01% 1427
2026
Q1 		– Sell
-100,536
Closed -$116K – 1757
2025
Q4 		$116K Buy
+100,536
New +$355K ﹤0.01% 1078
2025
Q3 		– Sell
-12,334
Closed -$13.6K – 1406
2025
Q2 		$13.6K Buy
+12,334
New +$13.9K ﹤0.01% 997

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's PYXS Position: Q2 2026 in Review

Quadrature Capital opened a new position in Pyxis Oncology (PYXS) in Q2 2026: 47,067 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #1427 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in PYXS as recently as Q4 2025.

Quadrature Capital first reported a position in PYXS in Q2 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Quadrature Capital held 47,067 shares of Pyxis Oncology worth $142K as of Q2 2026.
  • Pyxis Oncology was a new Quadrature Capital position in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1427 holding.
  • Quadrature Capital first reported a position in Pyxis Oncology in Q2 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.